February 2025 - Cancer Currents Blog
-
Can AI Help Predict Which Cancer Patients Should Be Treated with Immunotherapy?An AI-based tool called SCORPIO more accurately predicted whether cancer patients’ tumors would respond to checkpoint inhibitors than currently available tests, a new study found. It also predicted how long patients would live after treatment.
-
Abnormal Results from Prenatal Blood Test Could Point to Cancer in the MotherUnusual results from prenatal testing can indicate that the mother has cancer, a new study has found. The study also suggests that whole-body imaging as part of the follow-up on abnormal results can accurately identify these cancers.
-
FDA Approves Injectable Nivolumab, an Alternative to IV InfusionThe injectable form of nivolumab, called Opdivo Qvantig, is quicker and easier to give, several oncologists said, and is just as effective as the intravenous form. Injectable forms of other immunotherapies are also on the horizon.
-
Many Men with Metastatic Prostate Cancer Are Not Getting the Recommended Treatments, Study FindsMany U.S. doctors aren’t using the recommended initial treatments for their patients with hormone-sensitive metastatic prostate cancer, a new study has found. Often, it’s because they aren’t up to date on the latest treatment recommendations or because of side effect concerns.
-
Blinatumomab Boosts Chemotherapy as Initial Treatment for Some Kids with ALLFollowing positive results from a clinical trial, the immunotherapy drug blinatumomab (Blincyto) is expected to become part of the standard initial treatment for many kids with B-cell acute lymphoblastic leukemia, the most common form of childhood cancer.